Cramer: Hewlett's Back
Health Care: Drugs
United Therapeutics Corporation (UTHR: NASDAQ)
$67.25 -0.57 | -0.84%
05/23/13 - 02:35 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | 304.44M | 217.87M | 105.92M | 19.46M |
| Operating Gains/Losses | 1.43M | 2.61M | 967.00K | -1.85M |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | -23.99M | -16.16M | -23.45M | -21.96M |
| (Increase) Decrease in Inventories | -5.93M | -16.06M | -9.20M | -9.06M |
| (Increase) Decrease In Other Current Assets | -2.35M | -3.63M | -4.78M | -196.00K |
| (Decrease) Increase In Payables | -37.21M | 16.66M | -2.73M | -3.64M |
| (Decrease) Increase In Other Current Liabilities | 14.40M | 3.60M | 25.61M | -19.85M |
| (Increase) Decrease In Other Working Capital | -145.76M | -93.56M | -59.68M | -2.10M |
| Other Non-Cash Items | 183.13M | 96.60M | 100.20M | 105.78M |
| Net Cash From Continuing Operations | 323.63M | 250.20M | 211.53M | 97.62M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | 323.63M | 250.20M | 211.53M | 97.62M |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 0.00 | 36.20M | 0.00 |
| Purchases of Property, Plant & Equipment | -111.90M | -35.98M | -18.64M | -95.40M |
| Acquisitions | 0.00 | -3.55M | 0.00 | 1.21M |
| Purchases of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Cash from Investing Activities | 0.00 | -1.00K | 13.90M | -4.78M |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -163.36M | -121.33M | -209.24M | -160.52M |
| Issuance of Debt | 0.00 | 250.00M | 70.00M | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 16.80M | 24.40M | 85.43M | 32.07M |
| Repayment of Long-Term Debt | -999.00K | -251.04M | -31.44M | 0.00 |
| Repurchase of Capital Stock | -188.00M | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 3.05M | -241.44M | 22.77M | 4.41M |
| Net Cash From Financing Activities | -169.14M | -218.08M | 146.76M | 36.48M |
| Effect of Exchange Rate Changes | 229.00K | -269.00K | 2.76M | -2.68M |
| Net Change in Cash & Cash Equivalents | -8.65M | -89.49M | 151.81M | -29.10M |
Portfolios with UTHR
- Portfolio NameUser Type
- ProJoel Greenblatt - Gotham Ca...
- ContributorDrugs Facing FDA Approval i...
- UserBender
- ContributorStocks With Big Insider Buy...
- ContributorHot Biotech Stocks Traded b...
- Contributor8 Health Care Stocks Inside...
- ContributorStocks With Big Insider Buy...
- Contributor5 Biotech Stocks for 2012
- Contributor5 Low PEG / Low Beta Stocks
- Contributor13 Biotech Stocks Bought an...
Latest UTHR Headlines from TheStreet
- United Reaches New 52-Week High (UTHR) 05.22.13 | 10:05 am
- United Stock Hits New 52-Week High (UTHR) 05.14.13 | 02:05 pm
- Leaders of TheStreet's Drug Approval Contest 05.06.13 | 09:05 am
- United Rises On Unusually High Volume (UTHR) 04.30.13 | 04:04 pm
- United Stock Hits New 52-Week High (UTHR) 04.24.13 | 02:04 pm
- The Next Big Thing In Biotech: Decision Week
03.21.13 | 09:03 am - United Reaches New 52-Week High (UTHR) 03.20.13 | 01:03 pm
- United Reaches New 52-Week High (UTHR) 03.12.13 | 03:03 pm
- Best And Worst FDA Drug Approval Stocks of 2013 03.12.13 | 08:03 am
- Programmed Insider Buying? Yes, at Insmed and United Therapeutics 01.24.13 | 08:01 am
Press Releases for UTHR
- United Therapeutics Corporation To Announce First Quarter 2013 Financial Results Before Market Open On Thursday, April 25, 2013 - PR Newswire 04.18.13 | 06:04 am
- United Therapeutics Announces Receipt Of Second Complete Response Letter For Oral Treprostinil NDA - PR Newswire 03.25.13 | 05:03 am
- United Therapeutics Corporation To Announce Fourth Quarter And Annual 2012 Financial Results Before Market Open On Tuesday, February 26, 2013 - PR Newswire 02.19.13 | 06:02 am
- United Therapeutics Announces FDA Acceptance Of Resubmission Of Oral Treprostinil NDA - PR Newswire 02.14.13 | 06:02 am
- United Therapeutics Announces Additional $420 Million Share Repurchase Program - PR Newswire 02.04.13 | 06:02 am
- United Therapeutics Corporation To Announce Third Quarter 2012 Financial Results Before Market Open On Thursday, November 1, 2012 - PR Newswire 10.25.12 | 06:10 am
- United Therapeutics Announces Receipt Of Complete Response Letter For Oral Treprostinil NDA - PR Newswire 10.23.12 | 04:10 pm
- United Therapeutics Announces Collaboration With Ascendis Pharma To Develop Self-Injectable Treprostinil For Pulmonary Arterial Hypertension - PR Newswire 09.20.12 | 06:09 am
- United Therapeutics Corporation To Announce Second Quarter 2012 Financial Results Before Market Open On Thursday, July 26, 2012 - PR Newswire 07.19.12 | 06:07 am
- United Therapeutics Announces Additional $100 Million Share Repurchase Program - PR Newswire 06.27.12 | 06:06 am
Partner Headlines for UTHR
- Indexes Recover Early Losses As Turnover Picks Up - Investor's Business Daily 04.30.13 | 01:04 pm
- Major Averages End Near Highs But Volume Lacks Conviction - Investor's Business Daily 04.29.13 | 05:04 pm
- United Therapeutics Earnings: Here’s Why Investors are Selling Shares Now - Wall St. Cheat Sheet 04.25.13 | 01:04 pm
- Stocks Defend Broad Advance; Western Digital, Teradyne Surge - Investor's Business Daily 04.25.13 | 12:04 pm
- Biotechs Near Highs In A Week Of Key Earnings Reports - Investor's Business Daily 04.24.13 | 05:04 pm
- Stock Market Closes Mixed; Housing Plays Attract Buyers - Investor's Business Daily 04.24.13 | 04:04 pm
- United Therapeutics Corp. (UTHR): Today's Most Compelling Stock Buy - NASDAQ 04.22.13 | 06:04 pm
- Earnings Report Looms For United Therapeutics - Investor's Business Daily 04.22.13 | 05:04 pm
- United Therapeutics Holds 10-Week Despite FDA Setback - Investor's Business Daily 04.08.13 | 05:04 pm
- Brainstorm's Breakthrough ALS Clinical Data Shows The Promise In Stem Cell Therapy - Seeking Alpha 03.28.13 | 09:03 am
